| Ytd | 23.71% | |
| 1y | 218.36% |
| Open | 28.25 | Prev Close | 28.17 | Low | 28.25 | High | 29.57 | Mkt Cap | 2.97B |
| Vol | 1.08M | Avg Vol | 1.28M | EPS | -3.26 | P/E | -9.06 | Forward P/E | -9.66 |
| Beta | 0.80 | Short Ratio | 12.25 | Inst. Own | 72.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 26.20 | 200-d Avg | 22.73 | 1yr Est | 35.75 |
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmac
HC Wainwright raised its price forecast for Arcus Biosciences Inc. (NASDAQ:RCUS), citing the aggress
This is the first study to comprehensively interconnect clinical outcomes from patients receiving a
On Thursday, 369 companies hit new 52-week lows.
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua